115 related articles for article (PubMed ID: 16108827)
1. Hodgkin's lymphoma cells are efficiently engrafted and tumor marker CD30 is expressed with constitutive nuclear factor-kappaB activity in unconditioned NOD/SCID/gammac(null) mice.
Dewan MZ; Watanabe M; Ahmed S; Terashima K; Horiuchi S; Sata T; Honda M; Ito M; Watanabe T; Horie R; Yamamoto N
Cancer Sci; 2005 Aug; 96(8):466-73. PubMed ID: 16108827
[TBL] [Abstract][Full Text] [Related]
2. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
Dewan MZ; Terunuma H; Toi M; Tanaka Y; Katano H; Deng X; Abe H; Nakasone T; Mori N; Sata T; Yamamoto N
Cancer Sci; 2006 Dec; 97(12):1381-7. PubMed ID: 16995875
[TBL] [Abstract][Full Text] [Related]
3. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
Bargou RC; Emmerich F; Krappmann D; Bommert K; Mapara MY; Arnold W; Royer HD; Grinstein E; Greiner A; Scheidereit C; Dörken B
J Clin Invest; 1997 Dec; 100(12):2961-9. PubMed ID: 9399941
[TBL] [Abstract][Full Text] [Related]
4. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
[TBL] [Abstract][Full Text] [Related]
5. Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo.
Dewan MZ; Terunuma H; Takada M; Tanaka Y; Abe H; Sata T; Toi M; Yamamoto N
Breast Cancer Res Treat; 2007 Sep; 104(3):267-75. PubMed ID: 17066321
[TBL] [Abstract][Full Text] [Related]
6. The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in vitro and affects antitumor activity in models of Hodgkin's disease.
Wahl AF; Klussman K; Thompson JD; Chen JH; Francisco LV; Risdon G; Chace DF; Siegall CB; Francisco JA
Cancer Res; 2002 Jul; 62(13):3736-42. PubMed ID: 12097283
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
8. Aberrant NF-kappaB2/p52 expression in Hodgkin/Reed-Sternberg cells and CD30-transformed rat fibroblasts.
Nonaka M; Horie R; Itoh K; Watanabe T; Yamamoto N; Yamaoka S
Oncogene; 2005 Jun; 24(24):3976-86. PubMed ID: 15782119
[TBL] [Abstract][Full Text] [Related]
9. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
10. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation.
Higuchi M; Matsuda T; Mori N; Yamada Y; Horie R; Watanabe T; Takahashi M; Oie M; Fujii M
Retrovirology; 2005 May; 2():29. PubMed ID: 15876358
[TBL] [Abstract][Full Text] [Related]
12. The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma.
Nakashima M; Ishii Y; Watanabe M; Togano T; Umezawa K; Higashihara M; Watanabe T; Horie R
Cancer Sci; 2010 Nov; 101(11):2490-6. PubMed ID: 20735433
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor-kappaB p52, which is associated with hyperphosphorylated Bcl-3.
Nishikori M; Ohno H; Haga H; Uchiyama T
Cancer Sci; 2005 Aug; 96(8):487-97. PubMed ID: 16108830
[TBL] [Abstract][Full Text] [Related]
14. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.
Ohsugi T; Horie R; Kumasaka T; Ishida A; Ishida T; Yamaguchi K; Watanabe T; Umezawa K; Urano T
Carcinogenesis; 2005 Aug; 26(8):1382-8. PubMed ID: 15831528
[TBL] [Abstract][Full Text] [Related]
16. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
[TBL] [Abstract][Full Text] [Related]
17. An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.
Tazzari PL; de Totero D; Bolognesi A; Testoni N; Pileri S; Roncella S; Reato G; Stein H; Gobbi M; Stirpe F
Haematologica; 1999 Nov; 84(11):988-95. PubMed ID: 10553158
[TBL] [Abstract][Full Text] [Related]
18. Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma. Studies with cell lines and animal studies.
Dietlein M; Börner SM; Fischer T; Hansen H; Schnell R; Zimmermanns B; Tawadros S; Engert A; Staak O; Pogge von Strandmann E; Kobe C; Schicha H; Schomäcker K
Nuklearmedizin; 2010; 49(3):97-105. PubMed ID: 20126826
[TBL] [Abstract][Full Text] [Related]
19. A novel xenograft model of cutaneous T-cell lymphoma.
Krejsgaard T; Kopp K; Ralfkiaer E; Willumsgaard AE; Eriksen KW; Labuda T; Rasmussen S; Mathiesen AM; Geisler C; Lauenborg B; Becker JC; Zhang Q; Wasik MA; Odum N; Woetmann A
Exp Dermatol; 2010 Dec; 19(12):1096-102. PubMed ID: 20629733
[TBL] [Abstract][Full Text] [Related]
20. Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines.
Ohsugi T; Kumasaka T; Okada S; Ishida T; Yamaguchi K; Horie R; Watanabe T; Umezawa K
Cancer Lett; 2007 Nov; 257(2):206-15. PubMed ID: 17764832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
